MDH2
Malate dehydrogenase, mitochondrial
Also known as: MDHM_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P40926
- Gene
- MDH2
- Ensembl
- ENSG00000146701
- Chromosome
- 7
- Canonical length
- 338 aa
- Protein class
- Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Mitochondria
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Malate dehydrogenase catalyzes the reversible oxidation of malate to oxaloacetate, utilizing the NAD/NADH cofactor system in the citric acid cycle. The protein encoded by this gene is localized to the mitochondria and may play pivotal roles in the malate-aspartate shuttle that operates in the metabolic coordination between cytosol and mitochondria. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2013]
Canonical amino-acid sequenceUniProt
338 residues, UniProt reviewed canonical sequence.
>P40926|MDH2
1 MLSALARPAS AALRRSFSTS AQNNAKVAVL GASGGIGQPL SLLLKNSPLV SRLTLYDIAH
61 TPGVAADLSH IETKAAVKGY LGPEQLPDCL KGCDVVVIPA GVPRKPGMTR DDLFNTNATI
121 VATLTAACAQ HCPEAMICVI ANPVNSTIPI TAEVFKKHGV YNPNKIFGVT TLDIVRANTF
181 VAELKGLDPA RVNVPVIGGH AGKTIIPLIS QCTPKVDFPQ DQLTALTGRI QEAGTEVVKA
241 KAGAGSATLS MAYAGARFVF SLVDAMNGKE GVVECSFVKS QETECTYFST PLLLGKKGIE
301 KNLGIGKVSS FEEKMISDAI PELKASIKKG EDFVKTLKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MDH2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 653 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 653 nTPM
- tongue: 562 nTPM
- heart muscle: 354 nTPM
- liver: 207 nTPM
- adrenal gland: 159 nTPM
- esophagus: 143 nTPM
Single-cell type
- esophageal suprabasal cells: 690 nCPM
- esophageal apical cells: 570 nCPM
- esophageal basal cells: 564 nCPM
- migrating cytotrophoblasts: 471 nCPM
- cytotrophoblasts: 387 nCPM
- late primary spermatocytes: 386 nCPM
Immune cell
- myeloid DC: 176 nTPM
- total PBMC: 175 nTPM
- non-classical monocyte: 165 nTPM
- plasmacytoid DC: 157 nTPM
- T-reg: 157 nTPM
- intermediate monocyte: 149 nTPM
Brain region
- cerebral cortex: 124 nTPM
- choroid plexus: 122 nTPM
- basal ganglia: 103 nTPM
- hypothalamus: 98 nTPM
- pons: 93 nTPM
- medulla oblongata: 91 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MDH2.
Disease | AllUniProt
Conditions MDH2 is implicated in, by any mechanism.
- Developmental and epileptic encephalopathy 51 (DEE51) MIM:617339
Disease | GeneticClinVar
21 pathogenic / likely-pathogenic of 736 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Developmental and epileptic encephalopathy, 51
- Infantile encephalopathy
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.81
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.03
- DepMap mean gene effect
- -0.23
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 9% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- aerobic respiration
- gluconeogenesis
- malate metabolic process
- malate-aspartate shuttle
- tricarboxylic acid cycle
Molecular functions
- identical protein binding
- L-malate dehydrogenase (NAD+) activity
- RNA binding
- L-malate dehydrogenase (NADP+) activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Lactate/malate dehydrogenase, N-terminal
- Malate dehydrogenase, active site
- L-lactate/malate dehydrogenase
- Lactate dehydrogenase/glycoside hydrolase, family 4, C-terminal
- Lactate/malate dehydrogenase, C-terminal
- NAD(P)-binding domain superfamily
- lactate/malate dehydrogenase, NAD binding domain
- lactate/malate dehydrogenase, alpha/beta C-terminal domain
- Malate dehydrogenase, type 1
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MDH2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MDH2 as an antibody target. Whether an autoantibody or antibody against MDH2 could matter depends on whether native MDH2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MDH2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MDH2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...